[email protected]/(408) 457-3700

About Micar21

"Medicines are getting more expensive to develop. These days, it takes about $1 billion and 10-12 years for a single new drug. Simulating millions of virtual medicines to find potential commercial candidates in weeks? That what we call truly transformative.

Micar Innovation aims to change that by using all novel advanced approaches supported also by own drug discovery screen technology and GPU power to predict, in advance, which potential drug candidate molecule will work, and which won't. The same is valid for an innovative cosmetics active substance. Our technology can tell the difference between great drug candidates and toxic ones, and discover new uses for old medicines. The result is fewer test tubes, fewer experiments, fewer failed drugs. Just new and better medicines, faster. Micar Innovation can help discover and than predict the effectiveness of new potential drug molecules, reducing the need for costly and time-consuming physical synthesis and testing."

You need to register as an accredited investor before we can show you the details of any investment opportunities.

VentureHealth is currently invite only.

Request An Invite!

Startup's Info

Location:
Sofia
Markets:
Biotechnology, Pharmaceuticals
Therapeutic Areas:
CNS / Neurology, Dentistry, Dermatology, Endocrinology, Gastroenterology, Genetic Disease, Hematology, Hepatology, Immunology, Infectious Diseases, Musculoskeletal, Nephrology, Ob / Gyn, Obesity, Oncology, Ophthalmology, Orthopedics, Other, Otolaryngology, Pediatrics / Neonatology, Plastic Surgery, Podiatry, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Rheumatology, Trauma, Urology, Vaccines, Vascular Diseases, Women's Health